Can Trastuzumab be reimbursed? How much does it cost by medical insurance?

Trastuzumab is sold under the brand name Herceptin in China and has entered the scope of Class B medical insurance, but it may be limited to patients who meet the indications for this drug, such as HER2-positive metastatic breast cancer and its adjuvant and The price of neoadjuvant therapy or for patients with HER2-positive metastatic gastric cancer is around RMB 6,000. Patients who meet the medical insurance reimbursement conditions can be reimbursed. This drug may be available in domestic pharmacies or hospitals, but the reimbursement ratios are different in different regions, and the price after reimbursement may be different.

Trastuzumab is an antibody that targetsHER2 (human epidermal growth factor receptor 2). HER2 is a protein that regulates cell growth and division in normal cells. However, in some tumors, abnormal increases in HER2 can lead to excessive growth and spread of tumor cells. Trastuzumab binds to the HER2 receptor, blocking HER2 activation and interfering with binding to other signaling pathway ligands. This can inhibit signal transduction within tumor cells and limit their proliferation and malignant transformation capabilities. Trastuzumab binding can also induce self-death (apoptosis) in HER2-positive tumor cells. This prevents tumor cells from continuing to grow and spread, thereby inhibiting tumor progression.

Trastuzumab exerts its therapeutic effect by targetingHER2 receptor, inhibiting signaling pathways, inducing apoptosis and enhancing immune stimulation. This makes trastuzumab one of the important drugs against HER2-positive breast cancer and gastric/esophageal cancer. The original trastuzumab drug has also been launched overseas. The drug ingredients of domestic and foreign original drugs are basically the same. For specific prices and drug details, you can consult the medical consultant. There is currently no generic drug of trastuzumab on the market.